Mechanisms of apomorphine cytoxicity towards rat glioma C6 cells: Protection by bovine serum albumin and formation of apomorphine-protein conjugates

Neuroscience Letters

Volumn 263, Issue 1, 1999, Pages 25-28

  El Bacha R S ^a   Netter, P ^a   Minn, A ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Apomorphine; Autoxidation; Cytotoxicity; Parkinson's disease; Protein adducts

Indexed keywords

APOMORPHINE; BOVINE SERUM ALBUMIN; CYSTEINE; MELANIN;

ANIMAL CELL; ARTICLE; AUTOOXIDATION; CELL PROTECTION; CONJUGATION; CYTOTOXICITY; GLIOMA CELL; LIVER MICROSOME; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; APOMORPHINE; CATTLE; CELL DEATH; CELL SURVIVAL; FREE RADICAL SCAVENGERS; GLIOMA; MELANINS; MICROSOMES, LIVER; OXIDATION-REDUCTION; RATS; SERUM ALBUMIN, BOVINE; TUMOR CELLS, CULTURED;

EID: 0033583101     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00088-9     Document Type: Article

References (19)

1. Albano E., Rundgren M., Harvison P.J., Nelson S.D., Moldéus P. Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. Mol. Pharmacol. 28:1985;306-311.
2. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta. 1366:1998;211-223.
3. Cheng N., Maeda T., Kume T., Kaneko S., Kochiyama H., Akaike A., Goshima Y., Misu Y. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res. 743:1996;278-283.
4. 2 and 6-hydroxydopamine. Mov. Disord. 13:1998;242-248.
5. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
6. Hastings T.G., Lewis D.A., Zigmond M.J. Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Adv. Exp. Med. Biol. 387:1996;97-106.
7. 3H]dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 63:1994;1126-1132.
8. Kent Van Tyle W., Burkman A.M. Spectrofluorimetric assay of apomorphine in brain tissue. J. Pharm. Sci. 60:1971;1736-1738.
9. Lai C.-T., Yu P.H. Dopamine- and L-β-3,4-dihydroxy phenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Biochem. Pharmacol. 53:1997;363-372.
10. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
11. Melamed E., Offen D., Shirvan A., Djaldetti R., Barzilai A., Ziv I. Levodopa toxicity and apoptosis. Ann. Neurol. 44:1998;S149-S154.
12. Montine T.J., Farris D.B., Graham D.G. Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation. J. Neuropathol. Exp. Neurol. 54:1995;311-319.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:1983;55-63.
14. Puig J.F., Tephly T.R. Isolation and purification of rat liver morphine UDP-glucuronosyltransferase. Mol. Pharmacol. 33:1986;97-101.
15. Rabinovic A.D., Hastings T.G. Role of endogenous glutathione in the oxidation of dopamine. J. Neurochem. 71:1998;2071-2078.
16. Schraermeyer U. Transformation of albumin into melanin by hydroxyl radicals. Comp. Biochem. Physiol. 108C:1994;281-288.
17. Smith R.V., Velagapudi R.B., McLean A.M., Wilcox R.E. Interactions of apomorphine with serum and tissue proteins. J. Med. Chem. 28:1985;613-620.
18. Ubeda A., Montesinos C., Payá M., Alcaraz M.J. Iron-reducing and free-radical-scavenging properties of apomorphine and some related benzylisoquinolines. Free Rad. Biol. Med. 15:1993;159-167.
19. van der Geest R., Kruger P., Gubbens-Stibbe J.M., Laar T.V., Bodde H.E., Danhof M. Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease. J. Chromatogr. B. 702:1997;131-141.